February 2016 Briefing – Ophthalmology
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for February 2016. This roundup includes the latest...
Anti-VEGF Agents Linked to Visual Acuity Improvement in DME
From baseline to two years, improvement noted with three anti-VEGF agents
USPSTF: Evidence Lacking for Visual Acuity Screening in Seniors
Grade I recommendation for asymptomatic adults aged 65 years or older without vision problems
Vitiligo Patients Often Exhibit Abnormal Ocular Findings
Patients have significant differences in Schirmer test results, lens, fundus findings
Addition of Amphotericin B to Optisol-GS Needs Further Study
Authors call for more research on the addition of amphotericin B to Optisol-GS
Topical Dorzolamide-Timolol Beneficial in Neovascular AMD
Findings in eyes with neovascular AMD and incomplete response to anti-VEGF therapy
Suggestions for Optimizing Practice Feedback Effectiveness
Practice feedback interventions relate to nature of desired action, feedback display, delivery of feedback
Many Med Schools Appear Unwelcoming Regarding Disability
Only one-third of medical schools have technical standards supporting accommodating disabilities
CDC: Number of Uninsured Persons in U.S. Down Since 2013
Increase in percentage of adults, children with private health insurance coverage from 2013 to 2015
Physicians Concerned By Increasing Cost of Generics
Pennsylvania docs call for state- and national-level medical associations to address issue
